The National Agency for Food and Drug Administration and
Control has approved the use of the Johnson and Johnson COVID-19 vaccine in
Nigeria.
The agency’s Director-General, Prof Moji Adeyeye, made this
known in a statement issued on Tuesday signed by the agency’s spokesperson, Dr
Abubakar Jimoh.
The statement was titled “NAFDAC grants emergency use
authorisation for the ‘johnson and johnson’ vaccine’
It read, “NAFDAC is hereby granting conditional emergency use authorisation for Janssen Covid-19 vaccine to prevent COVID’19 in people from 18 years of age
“After a thorough
evaluation, the NAFDAC vaccine committee concluded that the data on the vaccine
were robust and met criteria for efficacy, safety, and quality ”
According to her, data has also shown that the benefits of
the vaccine outweigh its potential risk hence the need for approval.
She also said that results from a clinical trial involving
people in the United States, South Africa, and Latin America countries have
shown that Janssen Covid-19 vaccine was very useful in preventing Covid-19 in
people from 18 years of age.
Unlike the AstraZeneca Vaccine which is administered in two
doses, the Janssen vaccine Is administered in a single dose.
Advertise on NigerianEye.com to reach thousands of our daily users
No comments
Post a Comment
Kindly drop a comment below.
(Comments are moderated. Clean comments will be approved immediately)
Advert Enquires - Reach out to us at NigerianEye@gmail.com